NEW YORK, Sept. 10, 2013 /PRNewswire-USNewswire/ -- The fashion world's power players are often on the front lines supporting, advocating and raising awareness for many philanthropic, charitable and scientific causes. It is their incredible star wattage that draws attention from the media and raises awareness in the community. During this World Alzheimer's Month, celebrity designer Patricia Gomez-Gracia steps up to add her star power and creative talent to benefit the Alzheimer's Drug Discovery Foundation (ADDF).
Gomez-Gracia has designed an absolutely stunning Horizon Tank top exclusively for the ADDF's September 17th Fall Luncheon & Symposium "Hope on the Horizon – New Drugs for Alzheimer's Disease'. The Horizon Tank is a fall fashion must-have, hand-sewn with a gorgeous palette of blue and yellow sequins in different sizes onto softest, silk georgette. The tank has a beautiful drape and is available in U.S. sizes S, M & L for $450.00. (50% of proceeds benefits ADDF). Orders can be placed on the Gomez-Gracia website: http://www.gomez-gracia.com/product.aspx?catid=19.
The luncheon and symposium will honor Liz and Randal Sandler with the Charles Evans Award for their longtime commitment to the Alzheimer's community. The event, hosted by Paula Zahn, Norah O'Donnell, and chaired by Leonard A. Lauder, ADDF Co-Founder and Chairman, will announce promising developments in treatments to detect, prevent and cure Alzheimer's and related dementias. With special presentations by Howard Fillit, MD, Executive Director and Chief Science officer of the ADDF and Jeffrey L. Cummings, MD, ScD, Director, Cleveland Clinic Lou Ruvo Center for Brain Heath; Camille and Larry Ruvo Chair for Brain Health; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
For too long, the facts about Alzheimer's, the diagnosis and symptoms have been kept in the dark. As mysterious, taboo and frightening a topic as cancer was 30 years ago, Alzheimer's is a progressive, fatal disease of the brain that affects an estimated 5.24 million people in the US. There are no treatments currently available to treat or even slow the disease. But there is hope on the horizon.
About the ADDF
Founded in 1998 by Leonard A. and Ronald S. Lauder, the mission of the Alzheimer's Drug Discovery Foundation (ADDF) is to rapidly accelerate the discovery of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. The ADDF f has invested nearly $60 million to fund 400 Alzheimer's drug discovery programs in academic centers and biotechnology companies in 18 countries. For more information, please visit www.AlzDiscovery.org.
SOURCE Alzheimer's Drug Discovery Foundation